CTCs as a prognostic and predictive biomarker for stage II/III Colon Cancer: a companion study to the PePiTA trial

BACKGROUND: Adjuvant therapy improves the prognosis of stage II & III colon cancer patients. Unfortunately, most patients do not benefit from this treatment. PePITA (NCT00994864) is a prospective, multicenter, non-randomized study whose primary objective is to predict the outcome of adjuvant the...

Descripción completa

Detalles Bibliográficos
Autores principales: Rothé, Françoise, Maetens, Marion, Rouas, Ghizlane, Paesmans, Marianne, Van den Eynde, Marc, Van Laethem, Jean-Luc, Vergauwe, Philippe, Deboever, Guido, Bareche, Yacine, Vandeputte, Caroline, Ignatiadis, Michail, Hendlisz, Alain
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6446374/
https://www.ncbi.nlm.nih.gov/pubmed/30943928
http://dx.doi.org/10.1186/s12885-019-5528-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6446374/
https://www.ncbi.nlm.nih.gov/pubmed/30943928
http://dx.doi.org/10.1186/s12885-019-5528-1

Ejemplares similares